Figure 1From: Sodium valproate-induced congenital cardiac abnormalities in mice are associated with the inhibition of histone deacetylaseDose-dependent cardiac abnormalities in fetal mice prenatally exposed to NaVP. Cardiac abnormality rate increased significantly in fetal mice (gestation day 19) after prenatal exposure to NaVP (pregnant female mice received a one-time injection of NaVP on gestation day 7 at various doses). The cardiac abnormality caused by NaVP shows a dose-dependent pattern with the highest rate in the group of a treatment dose at 700 mg/kg body weight. * P < 0.05 vs. control without sodium valproate treatment.Back to article page